The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.
Open accessAbstract
Prostaglandin E2 (PGE2) inhibits fibroblast proliferation and collagen synthesis. In this study, we compared lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis (F-IPF) and from patients undergoing resectional surgery for lung cancer (F-nl) with respect to their capacity for PGE2 synthesis and their expression and regulation of cyclooxygenase (COX) proteins. Basal COX activity, assessed by quantitating immunoreactive PGE2 synthesized from arachidonic acid, was twofold less (P < 0.05) in F-IPF than F-nl. In F-nl, incubation with the agonists PMA, LPS, or IL-1 increased COX activity and protein expression of the inducible form of COX, COX-2, and these responses were inhibited by coincubation with dexamethasone. By contrast, F-IPF failed to demonstrate increases in COX-2 protein expression or COX activity in response to these agonists. Under conditions of maximal induction, COX activity in F-IPF was sixfold less than that in F-nl (P < 0.05). Our data indicate that F-IPF have a striking defect in their capacity to synthesize the antiinflammatory and antifibrogenic molecule PGE2, apparently because of a diminished induction of COX-2 protein. This reduction in the endogenous capacity of F-IPF to down-regulate their function via PGE2 may contribute to the inflammatory and fibrogenic response in IPF. Moreover, we believe that this represents the first description of a defect in COX-2 expression in association with a human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., & Seibert, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3228 · Cited by 1,310
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.
Fu, J. Y., Masferrer, J. L., Seibert, K., Raz, A., & Needleman, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44821-6 · Cited by 944
Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
Betz, M., & Fox, B. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.108 · Cited by 821
Jones, D. A., Carlton, D. P., McIntyre, T. M., Zimmerman, G. A., & Prescott, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52976-8 · Cited by 708
Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
O'Neill, G. P., & Ford-Hutchinson, A. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80263-t · Cited by 707
Vane, J. (1994) · Nature · doi:10.1038/367215a0 · Cited by 699
Prostaglandin endoperoxide synthase: structure and catalysis
Smith, W. L., & Marnett, L. J. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90119-3 · Cited by 601
A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.
O'Banion, M. K., Sadowski, H. B., Winn, V., & Young, D. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54491-4 · Cited by 557
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
Masferrer, J. L., Seibert, K., Zweifel, B., & Needleman, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3917 · Cited by 461
Fine, A., & Goldstein, R. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61441-3 · Cited by 399
Korn, J. H., Halushka, P. V., & LeRoy, E. C. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109698 · Cited by 281
Watters, L. C., King, T. E., Schwarz, M. I., Waldron, J. A., Stanford, R. E., & Cherniack, R. M. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.133.1.97 · Cited by 266
Cytokine Networks in the Regulation of Inflammation and Fibrosis in the Lung
Elias, J. A., Freundlich, B., Kern, J. A., & Rosenbloom, J. (1990) · Chest · doi:10.1378/chest.97.6.1439 · Cited by 262
Bitterman, P. B., Wewers, M. D., Rennard, S. I., Adelberg, S., & Crystal, R. G. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112364 · Cited by 232 · cited 2×
“However, it is also recognized that certain PGs, including PGE2, can exert potent inhibitory actions on leukocytes (38, 39), lymphocytes (40, 41), and fibroblasts (8, 9, 11, 42), which participate in the processes of inflammatory injury and repair.”
BackgroundEffect of cyclic AMP on the intracellular degradation of newly synthesized collagen.
Baum, B. J., Moss, J., Breul, S. D., Berg, R. A., & Crystal, R. G. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85816-7 · Cited by 180
Cytokines and pulmonary fibrosis.
Gauldie, J., Jordana, M., & Cox, G. (1993) · Thorax · doi:10.1136/thx.48.9.931 · Cited by 173
Kujubu, D. A., Reddy, S. T., Fletcher, B. S., & Herschman, H. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53338-x · Cited by 167
Goldstein, R. H., & POLGAR, P. R. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34174-7 · Cited by 155
Rolfe, M. W., Kunkel, S. L., Standiford, T. J., Chensue, S. W., Allen, R., Evanoff, H. L., Phan, S. H., & Strieter, R. M. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/5.5.493 · Cited by 145
Self-citationModulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin.
Baud, L., Perez, J., Denis, M., & Ardaillou, R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.4.1190 · Cited by 133
Borok, Z., Gillissen, A., Buhl, R., Hoyt, R. F., Hubbard, R. C., Ozaki, T., Rennard, S. I., & Crystal, R. G. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1080 · Cited by 131
Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages
O’Sullivan, M. G., Huggins, E. M., Meade, E. A., DeWitt, D. L., & McCall, C. E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91313-f · Cited by 127
Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process.
Elias, J. A., Rossman, M. D., Zurier, R. B., & Daniele, R. P. (1985) · PubMed · doi:10.1164/arrd.1985.131.1.94 · Cited by 107
Korn, J. H. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110873 · Cited by 106
Díaz, A., Reginato, A. M., & Jiménez, S. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50092-8 · Cited by 103
Elias, J. A. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.3.652 · Cited by 94
Fibrotic Reactions in the Lung: The Activation of the Lung Fibroblast
Goldstein, R. H., & Fine, A. (1986) · Experimental Lung Research · doi:10.3109/01902148609062828 · Cited by 88
Peters-Golden, M. L., McNish, R. W., Hyzy, R. C., Shelly, C., & Toews, G. B. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.1.263 · Cited by 85
Self-citationClark, J. G., Madtes, D. K., & Raghu, G. (1993) · Experimental Lung Research · doi:10.3109/01902149309064350 · Cited by 57
Jordana, M., Newhouse, M. T., & Gauldie, J. (1987) · Journal of Leukocyte Biology · doi:10.1002/jlb.42.1.51 · Cited by 37
Alterations in prostaglandin synthesis during senescence of human lung fibroblasts
POLGAR, P. R., & Taylor, L. (1980) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(80)90063-9 · Cited by 25
Cited by
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319
“disorder (143, 144), suggesting the fibrosis may be”
BackgroundKing, T. E., Pardo, A., & Selman, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60052-4 · Cited by 2,194
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Self-citationMyofibroblasts. I. Paracrine cells important in health and disease
Powell, D. W., Mifflin, R. C., Valentich, J. D., Crowe, S. E., Saada, J. I., & West, A. B. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.1.c1 · Cited by 924
Metadata
- Authors
- Wilborn, J., Crofford, L. J., Burdick, M. D., Kunkel, S. L., Strieter, R. M., & Peters-Golden, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-04-01
- Volume
- 95
- Issue
- 4
- Pages
- 1861-1868
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2013414651
- Cited by
- 392
- References
- 35
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.